Finding 2024-027
Coronavirus State and Local Fiscal Recovery Funds, ALN 21.027 - Subaward Information
Management Views
MDOT and LEO agree with parts a. and b. of the finding, respectively.
For part c., the Michigan Strategic Fund (MSF) agrees that the subaward agreements did not specify whether th...
Finding 2024-027
Coronavirus State and Local Fiscal Recovery Funds, ALN 21.027 - Subaward Information
Management Views
MDOT and LEO agree with parts a. and b. of the finding, respectively.
For part c., the Michigan Strategic Fund (MSF) agrees that the subaward agreements did not specify whether the award was for research and development (R&D) purposes. The omission occurred because MSF does not administer awards intended to support R&D activities under this program; accordingly, this designation was not included in the grant agreement.
MSF also agrees that the subaward agreements did not include an indirect cost rate. MSF did not fund indirect costs as part of this program; therefore, an indirect cost rate was not included in the grant agreement.
Planned Corrective Action
For part a., MDOT will incorporate into its current process all required subaward information to ensure it is reported to subrecipients, which will include, but not be limited to, UEI, Federal Award Identification Number (FAIN), federal award date, subaward period of performance start and end date, subaward budget period start and end date, federal awarding agency name, assistance listing number (ALN) title, identification of whether the award is for R&D, indirect cost rate for the federal award, an approved federally recognized indirect cost rate for the subrecipient, and the closeout terms and conditions. MDOT will also provide current subrecipients with the missing required subaward information.
For part b., the LEO Prosperity Division will review records to identify all subrecipients that were previously provided with incorrect FAINs and will provide them with correct information. In addition, the LEO Prosperity Division will implement a procedural change to have a reviewer check to ensure that award information is accurately stated before grant issuance.
For part c., to align with Uniform Guidance requirements (2 CFR 200.332(a)) all future agreements under the program will explicitly state that: 1) funding is not intended to support R&D activities; and 2) indirect costs are not eligible costs. All applicable current subrecipients will be notified of the same.
Anticipated Completion Date
a. September 30, 2025
b. July 31, 2025
c. July 31, 2025
Responsible Individual(s)
a. Gina Huhn, MDOT
Jean Ruestman, MDOT
b. Denise Flannery, LEO
c. Jay Williams, MSF
Amy Rencher, MSF
Gregory West, MSF
Christine Whitz, MSF
Christina Degrow, MSF